2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- PMID: 34101387
- PMCID: PMC9273041
- DOI: 10.1002/acr.24596
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Abstract
Objective: To develop updated guidelines for the pharmacologic management of rheumatoid arthritis.
Methods: We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to rate the certainty of evidence. A voting panel comprising clinicians and patients achieved consensus on the direction (for or against) and strength (strong or conditional) of recommendations.
Results: The guideline addresses treatment with disease-modifying antirheumatic drugs (DMARDs), including conventional synthetic DMARDs, biologic DMARDs, and targeted synthetic DMARDs, use of glucocorticoids, and use of DMARDs in certain high-risk populations (i.e., those with liver disease, heart failure, lymphoproliferative disorders, previous serious infections, and nontuberculous mycobacterial lung disease). The guideline includes 44 recommendations (7 strong and 37 conditional).
Conclusion: This clinical practice guideline is intended to serve as a tool to support clinician and patient decision-making. Recommendations are not prescriptive, and individual treatment decisions should be made through a shared decision-making process based on patients' values, goals, preferences, and comorbidities.
© 2021, American College of Rheumatology.
Comment in
-
Management of Rheumatoid Arthritis: Update From ACR.Am Fam Physician. 2022 Sep;106(3):340-342. Am Fam Physician. 2022. PMID: 36125998 No abstract available.
Similar articles
-
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.Arthritis Rheumatol. 2021 Jul;73(7):1108-1123. doi: 10.1002/art.41752. Epub 2021 Jun 8. Arthritis Rheumatol. 2021. PMID: 34101376
-
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25. doi: 10.1002/acr.22783. Epub 2015 Nov 6. Arthritis Care Res (Hoboken). 2016. PMID: 26545825 Review.
-
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.Arthritis Rheumatol. 2016 Jan;68(1):1-26. doi: 10.1002/art.39480. Epub 2015 Nov 6. Arthritis Rheumatol. 2016. PMID: 26545940 Review.
-
2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis.Arthritis Care Res (Hoboken). 2023 Aug;75(8):1603-1615. doi: 10.1002/acr.25117. Epub 2023 May 25. Arthritis Care Res (Hoboken). 2023. PMID: 37227116
-
2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis.Arthritis Rheumatol. 2023 Aug;75(8):1299-1311. doi: 10.1002/art.42507. Epub 2023 May 25. Arthritis Rheumatol. 2023. PMID: 37227071 Free PMC article.
Cited by
-
Application of disease activity index in rheumatoid arthritis management in Korea.J Rheum Dis. 2024 Oct 1;31(4):193-199. doi: 10.4078/jrd.2024.0077. Epub 2024 Aug 2. J Rheum Dis. 2024. PMID: 39355548 Free PMC article. Review.
-
"How are you?" Perspectives From Patients and Health Care Providers of Text Messaging to Support Rheumatoid Arthritis Care: A Thematic Analysis.ACR Open Rheumatol. 2024 May;6(5):276-286. doi: 10.1002/acr2.11652. Epub 2024 Feb 20. ACR Open Rheumatol. 2024. PMID: 38376004 Free PMC article.
-
Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study.BMJ Open. 2024 Feb 20;14(2):e076131. doi: 10.1136/bmjopen-2023-076131. BMJ Open. 2024. PMID: 38382962 Free PMC article.
-
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis.Rheumatol Ther. 2023 Feb;10(1):73-93. doi: 10.1007/s40744-022-00500-6. Epub 2022 Oct 13. Rheumatol Ther. 2023. PMID: 36227530 Free PMC article.
-
Semi-automated socio-anthropologic analysis of the medical discourse on rheumatoid arthritis: Potential impact on public health.PLoS One. 2022 Dec 29;17(12):e0279632. doi: 10.1371/journal.pone.0279632. eCollection 2022. PLoS One. 2022. PMID: 36580470 Free PMC article.
References
-
- Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2016;68:1–26. - PubMed
-
- Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762–84. - PubMed
-
- Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625–39. - PMC - PubMed
-
- Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Rheumatol 2017;69:1538–51. - PubMed
-
- Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse ME, Lockshin MD, et al. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken) 2020; 72:461–88. - PubMed